GGrantIndex
Sort

64,565 grants matching drug discovery

Epigenetics-Based Autism Treatment with Animal Models and Human Stem Cells

$599,088
Zhen Yan · State University Of New York At Buffalo · R01 · FY2024 · NS

Stanford Neuroscience Research Cores for Gene Vectors, Microscopy, and Behavios

$599,081
Gary K Steinberg · Stanford University · P30 · FY2019 · NS

Discovery of Glutaryl-CoA Dehydrogenase inhibitors for melanoma and pancreatic cancer

$599,074
Eduard A. Sergienko · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · CA

Request for a 500 MHz NMR console and nitrogen-cooled cryoprobe

$599,058
Andrew L Lee · Univ Of North Carolina Chapel Hill · S10 · FY2022 · OD

Exploring the metabolism of non-replicating and drug-resistant TB

$599,050
Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

Type-2 inflammation mediates olfactory loss in Chronic Rhinosinusitis: mechanisms and therapeutic opportunities

$599,049
Bruce K Tan · Northwestern University At Chicago · R01 · FY2018 · DC

SyncroPatch 384 Automated Patch Clamp Instrument

$599,040
Alfred L George · Northwestern University · S10 · FY2023 · OD

Manipulation of the host cell inflammasome by Mycobacterium tuberculosis

$599,019
Volker Briken · Univ Of Maryland, College Park · R01 · FY2022 · AI

High-Throughput Automated Patch Clamp System

$599,014
John L Spudich · University Of Texas Hlth Sci Ctr Houston · S10 · FY2022 · OD

An AVANCE NEO 400 MHz NMR Spectrometer for Chemical Biology and Drug Discovery

$599,000
Ming-Ming Zhou · Icahn School Of Medicine At Mount Sinai · S10 · FY2020 · OD

Informatics Tools for Pharmacogenomic Discovery using Practice-based Data

$598,996
Joshua C. Denny · Vanderbilt University · R01 · FY2015 · GM

Small Molecule Screening

$598,984
Stephen Lory · Harvard Medical School · U54 · FY2008 · AI

Cryopreservation and nanowarming enables whole liver banking for transplantation, cell therapy and biomedical research

$598,916
Erik Brian Finger · University Of Minnesota · R01 · FY2025 · DK

Synthesis of Antiinfective Agents

$598,892
Samuel J Danishefsky · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA

Parallel Multimodal High-throughput screening to identify activators of the orexin receptors

$598,887
Theodore M Kamenecka · Scripps Florida · R01 · FY2018 · MH

AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS

$598,885
Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA

A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria

$598,787
Molly A Hughes · University Of Virginia · R01 · FY2020 · AI

Targeting hepatitis B virus cccDNA during HBV/HIV co-infection

$598,764
Alexander Ploss · Princeton University · R01 · FY2024 · AI

Implementing A QSP Platform to Predict and Test Drugs for Metabolic Associated Fatty Liver Disease Genetic Variants in an iPSC-cell Based Human Biomimetic Liver Microphysiology System

$598,763
Mark T. Miedel · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK

Myosin Movement In Vitro - Molecular Characterization

$598,750
James A Spudich · Stanford University · R01 · FY2022 · GM

Myosin Movement In Vitro - Molecular Characterization

$598,750
James A Spudich · Stanford University · R01 · FY2024 · GM

Myosin Movement In Vitro - Molecular Characterization

$598,750
James A Spudich · Stanford University · R01 · FY2023 · GM

DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs

$598,736
Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Phenotypic assay for drug discovery and personalized medicine based on real-time vibrational spectroscopy enhanced by plasmonic metasurfaces

$598,729
Gennady Shvets · Cornell University · R21 · FY2020 · CA

Genetic Analysis of Toxinogenesis in Vibrio Cholerae

$598,721
John J Mekalanos · Harvard Medical School · R01 · FY2013 · AI